Medtronic (MDT) Wins US Patent Case Against Gore
Tweet Send to a FriendGet Alerts MDT Hot Sheet
Price: $52.92 -1.1%
Overall Analyst Rating:
NEUTRAL (
Down)
Dividend Yield: 2.7%
Revenue Growth %: +4.7%
Overall Analyst Rating:
NEUTRAL (
Down)Dividend Yield: 2.7%
Revenue Growth %: +4.7%
Trade MDT Now!
Medtronic, Inc. (NYSE: MDT) announced today that a judge in the Eastern District Court of Virginia last week ruled in Medtronic's favor in a patent case brought by W.L Gore & Associates, Inc.
The patent in question involved a method of making stent grafts, which are implantable medical devices used to treat aortic aneurysms. The judge determined that Medtronic's stent grafts did not infringe Gore's U.S. Patent No. 5,810,870.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The patent in question involved a method of making stent grafts, which are implantable medical devices used to treat aortic aneurysms. The judge determined that Medtronic's stent grafts did not infringe Gore's U.S. Patent No. 5,810,870.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Ackman's Pershing Square Says Herbalife (HLF) Refuses to Release Sales Data, Calls for Probe
- Netflix (NFLX) Launches Netflix Families in the U.K.
- Amazon.com (AMZN) Announces 'Birthday Gift' Initiative for Facebook (FB)
Create E-mail Alert Related Categories
Corporate News, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
